Paliperidone Palmitate

Records for this ingredient, by country (identity only).

ATC — · 4 markets · 73 records

Paliperidone Palmitate 4 markets · 73 records Forms

Filters

MarketAU 36 FR 17 SG 11 JP 9

Strength

AU 36 records · 12 shown of 13 Source TGA · Data as of 2026-10-28 · includes records with unknown status (not proof of sale)

234 mg per mL / per unit basis not statedinjection · extended-releasePALIPERIDONE ADVZ paliperidone (as palmitate)100 mg/1.0 mL modified release suspension for injection pre-filled syringe+4PALIPERIDONE-TEVA paliperidone (as palmitate) 25 mg/0.25 mL modified release suspension for injection pre-filled syringe、PALJUNA MONTHLY paliperidone (as palmitate) 50 mg/0.50 mL modified release suspension for injection pre-filled syringe、PALMEUX paliperidone (as palmitate) 100 mg/1.0 mL modified release suspension for injection pre-filled syringe、VALINO MONTHLY paliperidone (as palmitate) 25 mg/0.25 mL modified release suspension for injection pre-filled syringe unknown
156 mg per mL / per unit basis not statedinjection · extended-releasePALIPERIDONE ADVZ paliperidone (as palmitate)100 mg/1.0 mL modified release suspension for injection pre-filled syringe+4PALIPERIDONE-TEVA paliperidone (as palmitate) 25 mg/0.25 mL modified release suspension for injection pre-filled syringe、PALJUNA MONTHLY paliperidone (as palmitate) 50 mg/0.50 mL modified release suspension for injection pre-filled syringe、PALMEUX paliperidone (as palmitate) 100 mg/1.0 mL modified release suspension for injection pre-filled syringe、VALINO MONTHLY paliperidone (as palmitate) 25 mg/0.25 mL modified release suspension for injection pre-filled syringe unknown
117 mg per mL / per unit basis not statedinjection · extended-releasePALIPERIDONE ADVZ paliperidone (as palmitate)100 mg/1.0 mL modified release suspension for injection pre-filled syringe+4PALIPERIDONE-TEVA paliperidone (as palmitate) 25 mg/0.25 mL modified release suspension for injection pre-filled syringe、PALJUNA MONTHLY paliperidone (as palmitate) 50 mg/0.50 mL modified release suspension for injection pre-filled syringe、PALMEUX paliperidone (as palmitate) 100 mg/1.0 mL modified release suspension for injection pre-filled syringe、VALINO MONTHLY paliperidone (as palmitate) 25 mg/0.25 mL modified release suspension for injection pre-filled syringe unknown
78 mg per mL / per unit basis not statedinjection · extended-releasePALIPERIDONE ADVZ paliperidone (as palmitate)100 mg/1.0 mL modified release suspension for injection pre-filled syringe+4PALIPERIDONE-TEVA paliperidone (as palmitate) 25 mg/0.25 mL modified release suspension for injection pre-filled syringe、PALJUNA MONTHLY paliperidone (as palmitate) 50 mg/0.50 mL modified release suspension for injection pre-filled syringe、PALMEUX paliperidone (as palmitate) 100 mg/1.0 mL modified release suspension for injection pre-filled syringe、VALINO MONTHLY paliperidone (as palmitate) 25 mg/0.25 mL modified release suspension for injection pre-filled syringe unknown
39 mg per mL / per unit basis not statedinjection · extended-releasePALIPERIDONE ADVZ paliperidone (as palmitate)100 mg/1.0 mL modified release suspension for injection pre-filled syringe+4PALIPERIDONE-TEVA paliperidone (as palmitate) 25 mg/0.25 mL modified release suspension for injection pre-filled syringe、PALJUNA MONTHLY paliperidone (as palmitate) 50 mg/0.50 mL modified release suspension for injection pre-filled syringe、PALMEUX paliperidone (as palmitate) 100 mg/1.0 mL modified release suspension for injection pre-filled syringe、VALINO MONTHLY paliperidone (as palmitate) 25 mg/0.25 mL modified release suspension for injection pre-filled syringe unknown
1,560 mg per mL / per unit basis not statedinjectionINVEGA HAFYERA paliperidone (as palmitate) 700 mg in 3.5 mL modified release suspension for injection pre-filled syringe unknown
1,092 mg per mL / per unit basis not statedinjectionINVEGA HAFYERA paliperidone (as palmitate) 700 mg in 3.5 mL modified release suspension for injection pre-filled syringe unknown
312 mg/mL per mL / per unit basis not statedinjectionINVEGA TRINZA paliperidone (as palmitate) 175 mg modified release suspension for injection pre-filled syringe unknown
234 mg per mL / per unit basis not statedinjectionINVEGA SUSTENNA paliperidone (as palmitate) 50 mg modified release suspension for injection pre-filled syringe unknown
156 mg per mL / per unit basis not statedinjectionINVEGA SUSTENNA paliperidone (as palmitate) 50 mg modified release suspension for injection pre-filled syringe unknown
117 mg per mL / per unit basis not statedinjectionINVEGA SUSTENNA paliperidone (as palmitate) 50 mg modified release suspension for injection pre-filled syringe unknown
78 mg per mL / per unit basis not statedinjectionINVEGA SUSTENNA paliperidone (as palmitate) 50 mg modified release suspension for injection pre-filled syringe unknown

Other strengths: 1 · 1 dosage forms Otras concentraciones: 1 · 1 formas farmacéuticas 其余规格 1 个 · 涉及 1 种剂型其餘規格 1 個 · 涉及 1 種劑型

injection · 139 mg

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

FR 17 records · 12 shown of 12 Source Base de données publique des médic · Data as of 2026-11-03

234 mg per mL / per unit basis not statedinjection · extended-releasePALIPERIDONE BIOGARAN 100 mg, suspension injectable à libération prolongée en seringue préremplie+1XEPLION 100 mg, suspension injectable à libération prolongée
156 mg per mL / per unit basis not statedinjection · extended-releasePALIPERIDONE BIOGARAN 100 mg, suspension injectable à libération prolongée en seringue préremplie+1XEPLION 100 mg, suspension injectable à libération prolongée
117 mg per mL / per unit basis not statedinjection · extended-releasePALIPERIDONE BIOGARAN 100 mg, suspension injectable à libération prolongée en seringue préremplie+1XEPLION 100 mg, suspension injectable à libération prolongée
78 mg per mL / per unit basis not statedinjection · extended-releasePALIPERIDONE BIOGARAN 100 mg, suspension injectable à libération prolongée en seringue préremplie+1XEPLION 100 mg, suspension injectable à libération prolongée
39 mg per mL / per unit basis not statedinjection · extended-releasePALIPERIDONE BIOGARAN 100 mg, suspension injectable à libération prolongée en seringue préremplie+1XEPLION 100 mg, suspension injectable à libération prolongée
819 mg per mL / per unit basis not statedinjection · extended-releaseTREVICTA 175 mg, suspension injectable à libération prolongée
546 mg per mL / per unit basis not statedinjection · extended-releaseTREVICTA 175 mg, suspension injectable à libération prolongée
410 mg per mL / per unit basis not statedinjection · extended-releaseTREVICTA 175 mg, suspension injectable à libération prolongée
273 mg per mL / per unit basis not statedinjection · extended-releaseTREVICTA 175 mg, suspension injectable à libération prolongée
150 mg per mL / per unit basis not statedinjection · extended-releasePALIPERIDONE TEVA 100 mg, suspension injectable à libération prolongée
100 mg per mL / per unit basis not statedinjection · extended-releasePALIPERIDONE TEVA 100 mg, suspension injectable à libération prolongée
75 mg per mL / per unit basis not statedinjection · extended-releasePALIPERIDONE TEVA 100 mg, suspension injectable à libération prolongée

SG 11 records · 11 shown of 11 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

1,000 mg/5 mLinjection · extended-releaseINVEGA HAFYERA PROLONGED RELEASE SUSPENSION FOR IM INJECTION IN PREFILLED SYRINGE 700MG/3.5ML
700 mg/3.5 mLinjection · extended-releaseINVEGA HAFYERA PROLONGED RELEASE SUSPENSION FOR IM INJECTION IN PREFILLED SYRINGE 700MG/3.5ML
525 mg/2.625 mLinjection · extended-releaseINVEGA TRINZA PROLONGED RELEASE SUSPENSION FOR IM INJECTION 350MG/1.75ML
350 mg/1.75 mLinjection · extended-releaseINVEGA TRINZA PROLONGED RELEASE SUSPENSION FOR IM INJECTION 350MG/1.75ML
263 mg/1.315 mLinjection · extended-releaseINVEGA TRINZA PROLONGED RELEASE SUSPENSION FOR IM INJECTION 350MG/1.75ML
175 mg/0.875 mLinjection · extended-releaseINVEGA TRINZA PROLONGED RELEASE SUSPENSION FOR IM INJECTION 350MG/1.75ML
150 mg/1.5 mLinjection · extended-releaseINVEGA Sustenna Prolonged Release Suspension for IM Injection 150mg/1.5ml
100 mg/1 mLinjection · extended-releaseINVEGA Sustenna Prolonged Release Suspension for IM Injection 150mg/1.5ml
75 mg/0.75 mLinjection · extended-releaseINVEGA Sustenna Prolonged Release Suspension for IM Injection 150mg/1.5ml
50 mg/0.5 mLinjection · extended-releaseINVEGA Sustenna Prolonged Release Suspension for IM Injection 150mg/1.5ml
25 mg/0.25 mLinjection · extended-releaseINVEGA Sustenna Prolonged Release Suspension for IM Injection 150mg/1.5ml

JP 9 records · 9 shown of 9 Source 厚生労働省薬価基準収載品目リスト · Data as of 2026-11-01

525 mg per mL / per unit basis not statedinjectionゼプリオンTRI水懸筋注525mgシリンジ
350 mg per mL / per unit basis not statedinjectionゼプリオンTRI水懸筋注350mgシリンジ
263 mg per mL / per unit basis not statedinjectionゼプリオンTRI水懸筋注263mgシリンジ
175 mg per mL / per unit basis not statedinjectionゼプリオンTRI水懸筋注175mgシリンジ
150 mg per mL / per unit basis not statedinjectionゼプリオン水懸筋注150mgシリンジ
100 mg per mL / per unit basis not statedinjectionゼプリオン水懸筋注100mgシリンジ
75 mg per mL / per unit basis not statedinjectionゼプリオン水懸筋注75mgシリンジ
50 mg per mL / per unit basis not statedinjectionゼプリオン水懸筋注50mgシリンジ
25 mg per mL / per unit basis not statedinjectionゼプリオン水懸筋注25mgシリンジ

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.